News|Articles|October 2, 2024
EGFP mRNA Aggregation by SEC
Author(s)Phenomenex, Inc.
SEC data demonstrates mRNA aggregate analysis for vaccine stability. Optimal separation occurs at 100 mM NaCl and low flow rates, enhancing mRNA production quality.
Related Content
Trending on LCGC International
1
Sample Preparation Strategies for PFAS Analysis
2
GC-MS/MS Links Tooth-Layer Pollutant Traces to Autism Risk
3
The PFAS Analyst’s Wish List
4
AI/ML in Practice: Machine-learning Prediction of Chromatographic Retention Times for Small Molecules in Pharmaceutical Applications
5